Paradigm Biopharmaceuticals has selected Advanced Clinical as the clinical research organisation (CRO) to support its pivotal ...
Paradigm Biopharmaceuticals has selected Advanced Clinical as the preferred clinical research organisation for the phase III ...
GlobalData on MSN4d
MSD commences Phase III trial of DLBCL treatmentMSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...
Clinical trials can assist you in getting the right treatment for your condition. Before you consider it, here's what you should know.
GlobalData on MSN4d
Replicate’s rabies vaccine rivals Bavarian Nordic’s RavAlert at Phase IThe US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...
Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...
The art of saying no in clinical trials goes beyond simply delivering news; it involves maintaining relationships and ...
While 22 states have sued the Trump Administration to temporarily block a major policy change by the National Institute of ...
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback